The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease

被引:54
作者
Miki, K
Moore, DJ
Butler, RN
Southcott, E
Couper, RTL
Davidson, GP
机构
[1] Univ Adelaide, Womens & Childrens Hosp, Gastroenterol Unit, Adelaide, SA, Australia
[2] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia
关键词
D O I
10.1016/S0022-3476(98)70145-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: To investigate the relationship of intestinal permeability in children and adolescents with inflammatory bowel disease (IBD) to disease activity, disease extent, and response to therapy. Study design: Patients with new and established diagnoses of IBD (12 Crohn's disease [CD] and 18 ulcerative colitis [UC]) were studied. Intestinal permeability was evaluated by measuring with high-performance liquid chromatography 5-hour urinary excretion ratio of lactulose/L-rhamnose (L/Rh). Results: In 8 of 9 patients with active CD, the L/Rh ratio was higher than the reference range (0.006 to 0.074, n = 36). In inactive CD (n = 3) the L/Rh ratio was within the reference range. In 6 of 7 patients with active extensive UC, the L/Rh ratio was elevated. In inactive extensive UC (n = 6) the normal permeability ratio was shown. In both active CD and active extensive UC, the frequency of elevated intestinal permeability was significantly greater than values in both inactive forms. The permeability ratio was normal in 4 of 5 patients with active left-sided colitis. In 5 of 7 patients (3 CD, 4 UC), repeat permeability values entered the reference range after acute phase therapy. Two patients with persistently elevated intestinal permeability (1 CD, 1 UC) had a disease flare-up within 6 months. Conclusions: Intestinal permeability is a marker of disease activity in CD and extensive UC. Serial permeability test may be useful in monitoring disease activity.
引用
收藏
页码:750 / 754
页数:5
相关论文
共 32 条
[1]   A critical role for nitric oxide in intestinal barrier function and dysfunction [J].
Alican, I ;
Kubes, P .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1996, 270 (02) :G225-G237
[2]  
ANDRE C, 1990, HEPATO-GASTROENTEROL, V37, P113
[3]   ASSESSMENT OF THE LACTULOSE MANNITOL TEST IN CROHNS-DISEASE [J].
ANDRE, F ;
ANDRE, C ;
EMERY, Y ;
FORICHON, J ;
DESCOS, L ;
MINAIRE, Y .
GUT, 1988, 29 (04) :511-515
[4]  
BEST WR, 1976, GASTROENTEROLOGY, V70, P439
[5]   INTESTINAL PERMEABILITY - AN OVERVIEW [J].
BJARNASON, I ;
MACPHERSON, A ;
HOLLANDER, D .
GASTROENTEROLOGY, 1995, 108 (05) :1566-1581
[6]   THE EFFECT OF PHARMACOLOGICAL MODIFICATION OF GASTRIC-EMPTYING AND MOUTH-TO-CECUM TRANSIT-TIME ON THE ABSORPTION OF SUGAR PROBE MARKER MOLECULES OF INTESTINAL PERMEABILITY IN NORMAL MAN [J].
BRUNETTO, AL ;
PEARSON, ADJ ;
GIBSON, R ;
BATEMAN, DN ;
RASHID, MU ;
LAKER, MF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (03) :279-284
[7]   ABNORMAL LEUKOTRIENE-C4 RELEASE BY UNAFFECTED JEJUNAL MUCOSA IN PATIENTS WITH INACTIVE CROHNS-DISEASE [J].
CASELLAS, F ;
GUARNER, F ;
ANTOLIN, M ;
RODRIGUEZ, R ;
SALAS, A ;
MALAGELADA, JR .
GUT, 1994, 35 (04) :517-522
[8]   CELLOBIOSE MANNITOL TEST - PHYSIOLOGICAL-PROPERTIES OF PROBE MOLECULES AND INFLUENCE OF EXTRANEOUS FACTORS [J].
COBDEN, I ;
HAMILTON, I ;
ROTHWELL, J ;
AXON, ATR .
CLINICA CHIMICA ACTA, 1985, 148 (01) :53-62
[9]  
D'INCA R, 1992, Gastroenterology, V102, pA616
[10]   FECAL ALPHA-1-ANTITRYPSIN AND EXCRETION OF IN-111 GRANULOCYTES IN ASSESSMENT OF DISEASE-ACTIVITY IN CHRONIC INFLAMMATORY BOWEL DISEASES [J].
FISCHBACH, W ;
BECKER, W ;
MOSSNER, J ;
KOCH, W ;
REINERS, C .
GUT, 1987, 28 (04) :386-393